$58.35

3.00 (5.42%)

11/21/2008 4:01 PM

Johnson & Johnson (JNJ)

CAPS Rating:

Engaged in the research and development, manufacture and sale of a range of products in the health care field in many countries of the world.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating JNJ

Add Stock to Watchlist

What the Community Thinks

Total Members

9944 Outperforms

379 Underperforms

All-Stars

3020 Outperforms

62 Underperforms

Wall Street

30 Outperforms

0 Underperforms

Members bullish on JNJ are also bullish on:

Members bearish on JNJ are also bearish on:

Ticker Tags

Top Brands 2006 (61), Dow (30), Buffett Stock (46), Big Pharma (12), New Jersey (8), Pharmaceuticals (148), Medical Device (36), Dividend (191), Behemoth (33), Mega Cap (60), Diversified Conglomerate (16), S&P 500 (469), New Brunswick (1), Top Brands 2005 (60), Multinational Company (16)
Suggest a tag

Johnson & Johnson At A Glance

Current Price:	$58.35
Last Trade Time:	11/21/2008 4:01 PM
Open:	$56.48
Previous Close:	$55.35
Daily Range:	$54.49 - $58.51
52-Week Range:	$52.06 - $72.76
Volume:	30,700,942
Market Cap:	$154.85B
P/E Ratio:	12.49
Compare Our Special Broker Offers!

Stock Trends

JNJ VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for JNJ

Blue chip stocks cheap but not immune
11/21/2008 7:02:00 PM - AP
Final Glance: Pharmaceuticals companies
11/21/2008 6:14:00 PM - AP
Final Glance: Medical Devices companies
11/21/2008 6:14:00 PM - AP
Johnson & Johnson gets FDA approval for pain drug
11/21/2008 4:36:00 PM - AP

More Headlines...

Top Bull Pitch

Recs

24 Johnson & Johnson (JNJ)

Avatar BigSteve590 (42.90) Submitted: 3/25/08 8:06 AM

This is just a monster stock that you can always count on to performe well. The amount of research that goes on here is completely amazing. Nothing but good things to say about this stock.

Replies: 4 | Reply | Permalink

Top Bear Pitch

Recs

5 Johnson & Johnson (JNJ)

Avatar jep2224 (< 20) Submitted: 3/24/08 11:28 AM

Its all about the baby lotion.

Replies: 3 | Reply | Permalink

CAPS Members

Show Me:

Sort by:

picks per page. CHANGE

Results 1 - 5 of 1675 : 1 2 3 4 5 Next » Jump to page:

Recs 0 (JNJ) Iceman2399 (< 20) Submitted: 11/21/08 2:45 PM : Start Price: $55.20 JNJ Score: 5.06 They will not suffer as much as other consumer goods manufacturers during this and upcoming soft consumer buying cycle Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (JNJ) ETFinnovators (88.44) Submitted: 11/21/08 12:03 PM : Start Price: $54.91 JNJ Score: 6.65 Updated FDA Calendar of 75 Decision Dates http://www.etfinnovators.com/2008/11/updated-fda-calendar-of-75-decision.html The accompanying table [click to enlarge or download] includes an updated calendar of 75 expected FDA decision dates, which includes a full slate of expected action before year-end outline in my previous article. The last few days have been busy for antibiotics at the agency, resulting in sharply lower stock prices for Targanta Therapeutics (TARG) and Theravance (THRX). An FDA panel voted against Targanta's oritavancin, which has an upcoming decision in early December and sent shares crashing from 8 bucks before the decision to around $1.30 in trading today. Despite the panel endorsement for telavancin, shares of Theravance are losing about 25% today and the Company is still waiting for the FDA to issue a formal PDUFA date. Vanda Pharma (VNDA) received word yesterday from the FDA that its resubmission for iloperidone was accepted with a decision date expected by 5/6/09. Some other recent filings include Ista Pharma's (ISTA) NDA for eye drop Bepreve and two new filings by Johnson & Johnson (JNJ) for Comfyde and trabectedin. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (JNJ) doksavage (< 20) Submitted: 11/20/08 6:50 PM : Start Price: $56.48 JNJ Score: 4.98 Enough market share to survive and thrive. Unfairly beaten down due to deleveraging and redemptions. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (JNJ) jimstuy (78.85) Submitted: 11/20/08 4:44 PM : Start Price: $56.48 JNJ Score: 4.98 Being one of the largest traded companies. JNJ has enjoyed decent performance. I think the stock's recent downward trend is due to market weakness and macro economic woes. I still have faith in JNJ. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (JNJ) TbillerK (77.05) Submitted: 11/20/08 2:53 PM : Start Price: $57.07 JNJ Score: 5.48 wide range of consumer stapels Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Results 1 - 5 of 1675 : 1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 30 of 30

picks per page. CHANGE Expand All Pitches Collapse All Pitches

Top Pick	Member Name	Member Rating	Start Date	Call	Time Frame	Start Price	Stock Gain	S&P Gain	Score	Pitch
	TrackZacks	77.13	10/10/08		3M	$55.85	+4.48%	-14.31%	+18.79
	TrackJimCramer	85.65	07/10/08		3W	$66.51	-12.27%	-39.06%	+26.79
	TrackBobOlstein	< 20	06/18/08		5Y	$64.86	-10.04%	-43.63%	+33.59
	TrackChrisDavis	< 20	06/03/08		1Y	$66.18	-11.83%	-45.56%	+33.73
	TrackGaryBSmith	79.82	02/15/08		3W	$61.65	-5.36%	-43.88%	+38.53
	TrackStanfordRes	48.20	01/23/08		NS	$62.80	-7.09%	-40.75%	+33.67
	TrackHeebner	< 20	12/31/07		NS	$65.38	-10.75%	-48.13%	+37.38
	TrackRichAster	92.39	09/30/07		NS	$64.00	-8.83%	-50.30%	+41.47
	TrackSoros	< 20	09/30/07		NS	$64.00	-8.83%	-50.30%	+41.47
	TrackBuffett	92.31	09/30/07		NS	$64.00	-8.83%	-50.30%	+41.47
	TrackEveillard	85.91	09/30/07		NS	$64.00	-8.83%	-50.30%	+41.47
	TrackDodgeCox	94.99	09/30/07		NS	$64.00	-8.83%	-50.30%	+41.47
	TrackBrandes	< 20	09/30/07		NS	$64.00	-8.83%	-50.30%	+41.47
	TrackRichPzena	21.48	09/30/07		NS	$64.00	-8.83%	-50.30%	+41.47
	TrackHAndW	< 20	09/30/07		NS	$64.00	-8.83%	-50.30%	+41.47
	TrackSnow	67.69	09/30/07		NS	$64.00	-8.83%	-50.30%	+41.47
	TrackEdwardOwens	99.48	09/30/07		NS	$64.00	-8.83%	-50.30%	+41.47
	TrackJohnRogers	< 20	09/30/07		NS	$64.00	-8.83%	-50.30%	+41.47
	TrackVanDenBerg	87.33	09/30/07		NS	$64.00	-8.83%	-50.30%	+41.47
	TrackHillman	72.20	09/30/07		NS	$64.00	-8.83%	-50.30%	+41.47
	TrackBRogers	96.96	09/30/07		NS	$64.00	-8.83%	-50.30%	+41.47
	TrackMichaelBrus	74.39	08/08/07		1Y	$60.47	-3.50%	-49.15%	+45.64
	TrackPatDorsey	78.14	04/27/07		3Y	$61.69	-5.42%	-49.29%	+43.86
	TrackDeutscheSec	< 20	04/18/07		NS	$61.87	-5.69%	-48.53%	+42.85
	TrackMichaelSivy	97.68	03/20/07		1Y	$57.71	+1.10%	-46.21%	+47.31
	TrackCharlesPayn	< 20	02/24/07		3M